|By PR Newswire||
|August 7, 2014 11:00 AM EDT||
BOCA RATON, Fla., Aug. 7, 2014 /PRNewswire/ -- Akron is pleased to announce that it secured a strategic collaboration with Vivex Biomedical, Inc. on the use of its next-generation line of cryopreservation media, CryoNovo™.
Vivex Biomedical, Inc., from Marietta, GA, designs and develops innovative biologic products for regenerative medicine applications. Tracy Anderson, Vivex CEO, speaks to the imperative, "Vivex underscores its commitment to patient care in the confidence that only the highest quality products become therapeutic options. Our collaboration with Akron Biotech meets those standards of excellence."
Akron's glycerol-, serum- and DMSO-free cryoprotectant, CryoNovo™ T82, was developed as a non-toxic alternative to traditional DMSO-based cryopreservation media. CryoNovo™ T82 provides improved cell viability and functionality when used to preserve biological cells and tissues.
Akron's Claudia Zylberberg said, "We are extremely pleased to extend our new line of DMSO-free cryomedia toward exciting and important new applications, and the collaboration with Vivex is a prime example of the potential and significance of improved cryopreservation solutions which Akron pioneered."
CryoNovo™ T82 is used in the Vivex process of viable bone allograft preparation; retaining cell function, sustaining cell viability, and providing dependable cell identity that supports therapeutic intervention in orthopaedic and other regenerative medicine applications.
About Akron Biotech
Akron Biotech was founded in 2006, and is a privately owned company headquartered in South Florida, U.S. Akron has a strategic focus on delivering biological materials, technologies, and services for the regenerative medicine industry. As a global supplier, Akron manufactures components and specialized raw materials for cell therapy discovery, development, and commercialization, meeting the industry's needs worldwide. Our company's unique business model emphasizes flexibility, quality, and unparalleled service—from research and development to commercialization.
About Vivex Biomedical
Vivex Biomedical, Inc. is a biomaterials and human tissue manufacturer, distributor and developer located in Marietta, Georgia. Vivex is a pioneer and an innovator in the field of biomaterials and regenerative medicine that focuses on improving treatment options through engineered solutions that advance the clinical, surgical, and therapeutic care of patients. Vivex sets to raise a new standard in patient care through innovative health products delivered to meet the needs of a diverse and rapidly expanding population of patients that seek tissue repair over replacement as a management strategy for their healthcare issues.
SOURCE Vivex Biomedical, Inc.
Sep. 25, 2016 03:00 AM EDT Reads: 1,396
Sep. 25, 2016 02:45 AM EDT Reads: 846
Sep. 25, 2016 02:45 AM EDT Reads: 1,680
Sep. 25, 2016 02:15 AM EDT Reads: 1,202
Sep. 25, 2016 12:45 AM EDT Reads: 1,030
Sep. 25, 2016 12:45 AM EDT Reads: 1,927
Sep. 25, 2016 12:30 AM EDT Reads: 1,586
Sep. 24, 2016 09:45 PM EDT Reads: 1,604
Sep. 24, 2016 09:00 PM EDT Reads: 1,426
Sep. 24, 2016 08:30 PM EDT Reads: 1,443
Sep. 24, 2016 08:00 PM EDT Reads: 1,651
Sep. 24, 2016 07:00 PM EDT Reads: 2,792
Sep. 24, 2016 06:45 PM EDT Reads: 1,483
Sep. 24, 2016 04:30 PM EDT Reads: 1,512
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
Sep. 24, 2016 04:30 PM EDT Reads: 1,703